Adult-onset Still's disease following mRNA COVID-19 vaccination.

Sharabi, Amir; Shiber, Shachaf; Molad, Yair

Sharabi, Amir; Shiber, Shachaf; Molad, Yair.

Sharabi A; Rheumatology Institute, Rabin Medical Center, Beilinson Campus, Petach-Tikva Israel, affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Israel; Department of Microbiology and Immunology, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: isharabiamir@gmail.com.
Shiber S; Rheumatology Institute, Rabin Medical Center, Beilinson Campus, Petach-Tikva Israel, affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Molad Y; Rheumatology Institute, Rabin Medical Center, Beilinson Campus, Petach-Tikva Israel, affiliated with Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Clin Immunol ; 233: 108878, 2021 12.

Article in English | MEDLINE | ID: covidwho-1509675

Subject(s)

BNT162 Vaccine/administration & dosage; COVID-19/prevention & control; SARS-CoV-2/drug effects; Still's Disease, Adult-Onset/diagnosis; Adult; BNT162 Vaccine/adverse effects; BNT162 Vaccine/immunology; COVID-19/virology; Diagnosis, Differential; Female; Humans; Male; Middle Aged; RNA, Messenger/genetics; RNA, Messenger/immunology; SARS-CoV-2/immunology; SARS-CoV-2/physiology; Still's Disease, Adult-Onset/etiology; Still's Disease, Adult-Onset/therapy; Vaccination/adverse effects; Vaccination/methods

Keywords

Adult-onset Still's disease; COVID-19; mRNA vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Still's Disease, Adult-Onset / SARS-CoV-2 / COVID-19 / BNT162 Vaccine Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Clin Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google